Cargando…

1-O-Hexyl-2,3,5-Trimethylhydroquinone Ameliorates l-DOPA-Induced Cytotoxicity in PC12 Cells

1-O-Hexyl-2,3,5-trimethylhydroquinone (HTHQ) has previously been found to have effective anti-oxidant and anti-lipid-peroxidative activity. We aimed to elucidate whether HTHQ can prevent dopaminergic neuronal cell death by investigating the effect on l-DOPA-induced cytotoxicity in PC12 cells. HTHQ p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyun Jin, Kang, Jong Koo, Lee, Myung Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429301/ https://www.ncbi.nlm.nih.gov/pubmed/30823626 http://dx.doi.org/10.3390/molecules24050867

Ejemplares similares

Inhibitory Effect of 1-O-Hexyl-2,3,5-Trimethylhydroquinone on Dimethylnitrosamine-induced Liver Fibrosis in Male SD Rats
por: Jung, Yu-Ri, et al.
Publicado: (2010)

1-O-Hexyl-2,3,5-Trimethylhydroquinone Ameliorates the Development of Preeclampsia through Suppression of Oxidative Stress and Endothelial Cell Apoptosis
por: Jiang, Lai, et al.
Publicado: (2021)

Dose Dependence of 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone Promotion of Forestomach Carcinogenesis in Rats Pretreated with N‐Ethylnitrosourethane
por: Mizoguchi, Yasumoto, et al.
Publicado: (1998)

Effects of Anonaine on Dopamine Biosynthesis and l-DOPA-Induced Cytotoxicity in PC12 Cells
por: Lee, Jae Joon, et al.
Publicado: (2008)

Neuroprotective effects of 1‐O‐hexyl‐2,3,5‐trimethylhydroquinone on ischaemia/reperfusion‐induced neuronal injury by activating the Nrf2/HO‐1 pathway
por: Tang, Chaoliang, et al.
Publicado: (2020)

Strong Inhibition of 2‐Amino‐6‐methyldipyrido[l,2‐a:3′,2′‐d]imidazole‐induced Mutagenesis and Hepatocarcinogenesis by 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone
por: Hirose, Masao, et al.
Publicado: (1993)

Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells
por: Lee, Myung-Yul, et al.
Publicado: (2013)

Effects of Antioxidant 1‐O‐Hexyl‐2,3,5‐trimethylhydroquinone or Ascorbic Acid on Carcinogenesis Induced by Administration of Aminopyrine and Sodium Nitrite in a Rat Multi‐organ Carcinogenesis Model
por: Yada, Hideaki, et al.
Publicado: (2002)

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson’s disease treated with L-DOPA
por: Zhao, Ting Ting, et al.
Publicado: (2017)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
por: Huh, Eugene, et al.
Publicado: (2019)

Enantioselective Cytotoxicity Profile of o,p’-DDT in PC 12 Cells
por: Zhao, Meirong, et al.
Publicado: (2012)

L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017)

Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
por: Shin, Keon Sung, et al.
Publicado: (2015)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)

Eltoprazine modulated gamma oscillations on ameliorating L‐dopa‐induced dyskinesia in rats
por: Bi, Yuewei, et al.
Publicado: (2023)

L-Dopa and Behavior
por: Kebabian, John
Publicado: (1974)

L-Dopa and the Albino Riddle: Content of L-Dopa in the Developing Retina of Pigmented and Albino Mice
por: Roffler-Tarlov, Suzanne, et al.
Publicado: (2013)

Fucoxanthin Prevents Long-Term Administration l-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells
por: Liu, Jingwangwei, et al.
Publicado: (2022)

Identification of biochemical and cytotoxic markers in cocaine treated PC12 cells
por: Badisa, Ramesh B., et al.
Publicado: (2018)

Cytotoxic Effects of Coated Gold Nanoparticles on PC12 Cancer Cell
por: Zare Marzouni, Hadi, et al.
Publicado: (2018)

Herbs containing L- Dopa: An update
por: Ramya, Kuber B, et al.
Publicado: (2007)

L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023)

Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
por: Du, Huan, et al.
Publicado: (2015)

O,O′-Dimethyl (cyclohexylamido)thiophosphate
por: Sabbaghi, Fahimeh, et al.
Publicado: (2012)

Dicyclohexylammonium bis(chlorodifluoroacetato-κO)cyclohexyldiphenylstannate(IV)
por: Teo, Yin Yin, et al.
Publicado: (2008)

3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
por: Asanuma, Masato, et al.
Publicado: (2016)

Betalain production is possible in anthocyanin-producing plant species given the presence of DOPA-dioxygenase and L-DOPA
por: Harris, Nilangani N, et al.
Publicado: (2012)

Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH
por: Montioli, Riccardo, et al.
Publicado: (2013)

L-DOPA Is an Endogenous Ligand for OA1
por: Lopez, Vanessa M, et al.
Publicado: (2008)

Opioid system in L-DOPA-induced dyskinesia
por: Pan, Jing, et al.
Publicado: (2017)

l-Dopa and Brain Serotonin System Dysfunction
por: Stansley, Branden J., et al.
Publicado: (2015)

Electroanalytical Overview: The Determination of Levodopa (L-DOPA)
por: Crapnell, Robert D., et al.
Publicado: (2023)

Myricetin reduces cytotoxicity by suppressing hepcidin expression in MES23.5 cells
por: Deng, Han, et al.
Publicado: (2020)

Ameliorating the Developmental Neurotoxicity of Chlorpyrifos: A Mechanisms-Based Approach in PC12 Cells
por: Slotkin, Theodore A., et al.
Publicado: (2007)

Sodium valproate ameliorates aluminum-induced oxidative stress and apoptosis of PC12 cells
por: Iranpak, Forough, et al.
Publicado: (2019)

Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia
por: Fridjonsdottir, Elva, et al.
Publicado: (2021)

β-Lapachone ameliorates L-DOPA-induced dyskinesia in a 6-OHDA-induced mouse model of Parkinson's disease
por: Ryu, Young-Kyoung, et al.
Publicado: (2021)

Management of L-dopa overdose in the competitive inhibition state
por: Hinz, Marty, et al.
Publicado: (2014)

Striatal Astrocytes Act as a Reservoir for L-DOPA
por: Asanuma, Masato, et al.
Publicado: (2014)

Molecular Effects of L-dopa Therapy in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fvbk9u6a09brbc8mp5g9dbool0